• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 24623
Device Problem Material Deformation (2976)
Patient Problem Pain (1994)
Event Date 10/01/2020
Event Type  Injury  
Manufacturer Narrative
Date of event: the event date was not provided.The first date of the month of the aware date was used.
 
Event Description
It was reported that stent fracture that caused foot pain to the patient occurred.The patient presented with claudication.The 70% stenosed target lesion was located in the mildly tortuous and moderately calcified tibial artery.After a 0.014 inch guide wire crossed the lesion, a 2.50x38mm promus premier drug-eluting stent was deployed to treat the lesion and was post-dilated.However, post deployment, it was noted that the stent appeared to have a large gap or separation between struts 3 and 4 at the proximal end.The physician used angioplasty a second time and it still looked abnormal.The procedure was completed despite this.Upon follow-up, the patient complained on ongoing foot pain and it was noted that the stent appeared crushed and deformed.Additional balloon angioplasty was performed to rectify the crushed stent and a non-bsc stent was implanted to keep the vessel patent.
 
Event Description
It was reported that stent fracture that caused foot pain to the patient occurred.The patient presented with claudication.The 70% stenosed target lesion was located in the mildly tortuous and moderately calcified tibial artery.After a 0.014 inch guide wire crossed the lesion, a 2.50x38mm promus premier drug-eluting stent was deployed to treat the lesion and was post-dilated.However, post deployment, it was noted that the stent appeared to have a large gap or separation between struts 3 and 4 at the proximal end.The physician used angioplasty a second time and it still looked abnormal.The procedure was completed despite this.Upon follow-up, the patient complained on ongoing foot pain and it was noted that the stent appeared crushed and deformed.Additional balloon angioplasty was performed to rectify the crushed stent and a non-bsc stent was implanted to keep the vessel patent.It was further reported that the target lesion was located in the tibioperoneal trunk.
 
Manufacturer Narrative
D4 model number: corrected to 24623.D4 catalog number: corrected to 24623.Date of event: the event date was not provided.The first date of the month of the aware date was used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10771697
MDR Text Key214158124
Report Number2134265-2020-14932
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number24623
Device Catalogue Number24623
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/14/2020
Initial Date FDA Received11/02/2020
Supplement Dates Manufacturer Received11/12/2020
Supplement Dates FDA Received12/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-